PHARMACOSMOS A/S — Credit Rating and Financial Key Figures
CVR number: 15517085
Rørvangsvej 30, 4300 Holbæk
tel: 59485959
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 1 613 000.00 | 2 623 000.00 | |||
| Other operating income | 300 000.00 | 1 497 000.00 | |||
| Costs of manufacturing | - 368 000.00 | - 530 000.00 | |||
| Gross profit | 0.47 | 0.55 | 0.70 | 1 245 000.00 | 2 093 000.00 |
| Costs of management | - 295 000.00 | - 411 000.00 | |||
| Costs of distribution | - 174 000.00 | - 169 000.00 | |||
| Wages and salaries | - 202 000.00 | - 233 000.00 | |||
| Social security expenses | -19 000.00 | -25 000.00 | |||
| Other operating expenses | -96 000.00 | - 139 000.00 | |||
| EBIT | 0.47 | 0.55 | 0.70 | 917 000.00 | 2 359 000.00 |
| Other financial income | 152 000.00 | 207 000.00 | |||
| Other financial expenses | 30 000.00 | 341 000.00 | |||
| Net income from associates (fin.) | -63 000.00 | - 512 000.00 | |||
| Pre-tax profit | 1 039 000.00 | 2 225 000.00 | |||
| Income taxes | - 249 000.00 | - 603 000.00 | |||
| Net earnings | 790 000.00 | 1 622 000.00 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 59 000.00 | 81 000.00 | |||
| Intangible rights | 2 445 000.00 | ||||
| Intangible assets total | 59 000.00 | 2 526 000.00 | |||
| Buildings | 7 000.00 | 8 000.00 | |||
| Tangible assets total | 7 000.00 | 8 000.00 | |||
| Holdings in group member companies | 86 000.00 | 82 000.00 | |||
| Other non-current investments | -1 000.00 | ||||
| Investments total | 1.48 | 1.59 | 1.75 | 86 000.00 | 82 000.00 |
| Long term receivables total | |||||
| Raw materials and consumables | 29 000.00 | 63 000.00 | |||
| Finished products/goods | 140 000.00 | 174 000.00 | |||
| Inventories total | 169 000.00 | 237 000.00 | |||
| Current trade debtors | 236 000.00 | 376 000.00 | |||
| Current amounts owed by group member comp. | 1 033 000.00 | 1 210 000.00 | |||
| Current other receivables | 16 000.00 | 14 000.00 | |||
| Short term receivables total | 1 285 000.00 | 1 600 000.00 | |||
| Other current investments | 948 000.00 | 65 000.00 | |||
| Cash and bank deposits | 104 000.00 | 205 000.00 | |||
| Cash and cash equivalents | 1 052 000.00 | 270 000.00 | |||
| Balance sheet total (assets) | 1.48 | 1.59 | 1.75 | 2 658 000.00 | 4 723 000.00 |
Equity and liabilities (kDKK)
2023 | 2024 | |
|---|---|---|
| Share capital | 101 000.00 | 101 000.00 |
| Other reserves | 46 000.00 | 63 000.00 |
| Retained earnings | 699 000.00 | 411 000.00 |
| Profit of the financial year | 790 000.00 | 1 622 000.00 |
| Shareholders equity total | 1 636 000.00 | 2 197 000.00 |
| Non-current loans from credit institutions | 328 000.00 | 1 321 000.00 |
| Non-current other liabilities | 537 000.00 | |
| Non-current liabilities total | 328 000.00 | 1 858 000.00 |
| Current loans from credit institutions | 556 000.00 | 405 000.00 |
| Advances received | 43 000.00 | 34 000.00 |
| Current trade creditors | 60 000.00 | 99 000.00 |
| Short-term deferred tax liabilities | 61 000.00 | |
| Other non-interest bearing current liabilities | 35 000.00 | 69 000.00 |
| Current liabilities total | 694 000.00 | 668 000.00 |
| Balance sheet total (liabilities) | 2 658 000.00 | 4 723 000.00 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.